Lanchbury Jerry S's Form 4 filing
Myriad Genetics Inc (MYGN) · filed Sep 27, 2021
- Accession no.
- 0001219036-21-000029
- Filed
- Sep 27, 2021
- Trade date
- Sep 23-26, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $7.01K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lanchbury Jerry SCIK 0001219036 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2021 | Common Stock | SSaleDisposed | −200 | $35.06 | −$7,012 | 288,515 | Direct | |
| Sep 25, 2021 | Common Stock | FTax withholdingDisposed | −9,747 | $33.31 | −$324,672.57 | 278,768 | Direct | |
| Sep 26, 2021 | Common Stock | FTax withholdingDisposed | −3,633 | $33.31 | −$121,015.23 | 275,135 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.